AC Immune SA — Interim / Quarterly Report 2017

May 11, 2017

6-K 1 dp76049_6k.htm FORM 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May, 2017

Field: Rule-Page

Field: /Rule-Page

Commission File Number: 001-37891

AC IMMUNE SA

(Exact name of registrant as specified in its charter)

EPFL Innovation Park

Building B

1015 Lausanne, Switzerland

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

Field: Rule-Page

Field: /Rule-Page Field: Rule-Page

Field: /Rule-Page Field: Page; Sequence: 1

Field: /Page

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Andrea Pfeifer
Name:	Andrea Pfeifer
Title:	Chief Executive Officer

	Name:	Joerg Hornstein
	Title:	Chief Financial Officer
Date:	May 11, 2017

Field: Page; Sequence: 2

Field: /Page

Exhibit Index

| Exhibit
Number | Description |
| --- | --- |
| 99.1 | Interim Condensed Financial Statements (Unaudited) (IFRS) as of and for the Three Months Ended March 31, 2017 |
| 99.2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
| 99.3 | Press Release dated May 11, 2017 |
| 99.4 | AC Immune SA Articles of Association dated March 30, 2017 |

Field: Page; Sequence: 3; Options: Last

Field: /Page